A newly identified enzyme, IDO1, is a critical target for controlling inflammation and restoring healthy cholesterol metabolism in immune cells.
Most Recent Articles
Forecasting a Decade of Contraction in Development Assistance for Health (DAH), 2021–2030
New analysis reveals that unprecedented cuts in global health funding are projected to erase 15 years of financial progress, putting decades of health improvements at risk.
A Scoping Review of OTC Products for Depression: An Analysis of 209 Trials
A central review of 209 trials assesses whether popular over-the-counter supplements for depression are backed by science, revealing a complex picture of evidence, risk, and potential.
GLP-1 Agonists Linked to Increased GERD Risk Compared With SGLT-2 Inhibitors
In an extensive cohort study of patients with type 2 diabetes, use of GLP-1 receptor agonists was associated with a significantly higher risk for GERD compared to SGLT-2 inhibitors.
A Network Meta-Analysis of 42 Systemic Treatments for Chronic Urticaria
A landmark network meta-analysis of 93 studies has identified the most effective and safest systemic treatments for patients with chronic hives refractory to antihistamines.